Fisher HA - Search Results

1

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma.

Ross JS, Sheehan CE, Hayner-Buchan AM, Ambros RA, Kallakury BV, Kaufman RP Jr, Fisher HA, Rifkin MD, Muraca PJ. Ross JS, et al. Among authors: fisher ha. Cancer. 1997 Jun 1;79(11):2162-70. doi: 10.1002/(sici)1097-0142(19970601)79:11<2162::aid-cncr14>3.0.co;2-u. Cancer. 1997. PMID: 9179063

2

DNA ploidy of oncocytic-granular renal cell carcinomas and renal oncocytomas by image analysis.

Veloso JD, Solis OG, Barada JH, Fisher HA, Ross JS. Veloso JD, et al. Among authors: fisher ha. Arch Pathol Lab Med. 1992 Feb;116(2):154-8. Arch Pathol Lab Med. 1992. PMID: 1733409

3

Prostatic carcinosarcoma: case report and review of literature.

Nazeer T, Barada JH, Fisher HA, Ross JS. Nazeer T, et al. Among authors: fisher ha. J Urol. 1991 Nov;146(5):1370-3. doi: 10.1016/s0022-5347(17)38099-0. J Urol. 1991. PMID: 1942296 Review.

4

Verrucous carcinoma of the bladder.

Horner SA, Fisher HA, Barada JH, Eastman AY, Migliozzi J, Ross JS. Horner SA, et al. Among authors: fisher ha. J Urol. 1991 Jun;145(6):1261-3. doi: 10.1016/s0022-5347(17)38595-6. J Urol. 1991. PMID: 2033707 Review.

5

Association of p53 immunoreactivity with high gleason tumor grade in prostatic adenocarcinoma.

Kallakury BV, Figge J, Ross JS, Fisher HA, Figge HL, Jennings TA. Kallakury BV, et al. Among authors: fisher ha. Hum Pathol. 1994 Jan;25(1):92-7. doi: 10.1016/0046-8177(94)90177-5. Hum Pathol. 1994. PMID: 7508886

6

E-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade, DNA content, pathologic stage, and clinical outcome.

Ross JS, Figge HL, Bui HX, del Rosario AD, Fisher HA, Nazeer T, Jennings TA, Ingle R, Kim DN. Ross JS, et al. Among authors: fisher ha. Mod Pathol. 1994 Oct;7(8):835-41. Mod Pathol. 1994. PMID: 7530850

7

Alteration of the p53 locus in benign hyperplastic prostatic epithelium associated with high-grade prostatic adenocarcinoma.

Kallakury BV, Jennings TA, Ross JS, Breese K, Figge HL, Fisher HA, Figge J. Kallakury BV, et al. Among authors: fisher ha. Diagn Mol Pathol. 1994 Dec;3(4):227-32. doi: 10.1097/00019606-199412000-00003. Diagn Mol Pathol. 1994. PMID: 7532528

8

Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status.

Ross JS, Nazeer T, Figge HL, Fisher HA, Rifkin MD. Ross JS, et al. Among authors: fisher ha. Am J Clin Pathol. 1995 Jul;104(1):36-41. doi: 10.1093/ajcp/104.1.36. Am J Clin Pathol. 1995. PMID: 7541934

9

E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder.

Ross JS, del Rosario AD, Figge HL, Sheehan C, Fisher HA, Bui HX. Ross JS, et al. Among authors: fisher ha. Hum Pathol. 1995 Sep;26(9):940-4. doi: 10.1016/0046-8177(95)90081-0. Hum Pathol. 1995. PMID: 7672793

10

Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.

Ross JS, Figge H, Bui HX, del Rosario AD, Jennings TA, Rifkin MD, Fisher HA. Ross JS, et al. Among authors: fisher ha. Cancer. 1994 Nov 15;74(10):2811-8. doi: 10.1002/1097-0142(19941115)74:10<2811::aid-cncr2820741012>3.0.co;2-b. Cancer. 1994. PMID: 7954242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters